- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03860402
The Effect of Warm Local Anesthetic Solution on Epidural Anesthesia
The Effect of Warm Local Anesthetic Solution for Sensory Block on Epidural Anesthesia of Cesarean Delivery : a Randomized Controlled Study
Study Overview
Detailed Description
Spinal anesthesia has a shorter time to onset than epidural anesthesia, and the amount of local anesthetic administered is lower than that of epidural anesthesia, resulting in less systemic toxicity and superior block effect.
However, there are disadvantage that it is difficult to control the block height and the incidence of hypotension is high.
On the other hand, epidural anesthesia has the advantages of less sudden hypotension due to slow autonomic blockade, but it has a disadvantage that sensory nerve and motor nerve block time is delayed compared to spinal anesthesia.
The degree of nerve block for cesarean section surgery requires a high level of anesthesia above the T6 level, so the frequency of hypotension is high due to rapid sympathetic block after spinal anesthesia.
In this respect, hemodynamically stable epidural anesthesia is preferred when performing anesthesia for cesarean section.
The investigators are going to compare the onset and duration of nerve blockage with the use of pre-warmed (38°C) and room temperature (20°C) local anesthetic solutions (ropivacaine and fentanyl) on epidural anesthesia for cesarean section, and compare the incidence of complications such as hypotension, nausea and vomiting.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Yeongdeungpo-gu
-
Seoul, Yeongdeungpo-gu, Korea, Republic of, KS013
- KangNam Sacred Heart Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Among the pregnant women who were administered cesarean section in this study, those who agreed to participate in this study.
Exclusion Criteria:
- Fetal distress requiring fast delivery.
- Patients with hypersensitivity, allergic response, resistance to the drugs used in this study (fentanyl, ropivacaine, lidocaine).
- Patients who is not possible for regional anesthesia
- Patients who refused to participate in this study.
- Patients who cannot read or understand the agreement.
- Patients whose weight is less than 50kg or exceeds 100kg.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Pre-warmed drug
Pre-warmed (38°C) ropivacaine (7.5mg/ml) 19ml and fentanyl 50ug are injected via the epidural route at the L3-4 interspace.
|
temperature of drug
|
Room temperature drug
Room temperature (20°C) ropivacaine (7.5mg/ml) 19ml and fentanyl 50ug are injected via the epidural route at the L3-4 interspace.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Onset time of epidural anesthesia (up to T6 level)
Time Frame: During the operation
|
After the administration of epidural local anesthetics the sensory block level is checked every 2 minutes for 20 minutes, every 10 minutes during operating period, and every 10 minutes for 60 minutes in the recovery room.
The sensory block level is assessed using the pinprick test method.
|
During the operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of hypotension
Time Frame: During the operation
|
When systolic blood pressure is less than 90 mmHg or mean arterial pressure is less than 60 mmHg, 30 mcg of phenylephrine is administrated.
If bradycardia(HR<50) is accompanied, 4mg of ephedrine is injected.
|
During the operation
|
Incidence of nausea and vomiting
Time Frame: From the time of epidural injection to 1 hour after entering recovery room
|
Record the nausea and vomiting that occurred in the operating room and in the recovery room after administration of the local anesthetic.
If there is nausea and vomiting after surgery, ramosetron (0.3mg) should be administered if the postoperative nausea and vomiting(PONV) grade is 1 or more and symptoms are severe enough to require medication.
|
From the time of epidural injection to 1 hour after entering recovery room
|
Collaborators and Investigators
Investigators
- Principal Investigator: Eun Mi Choi, MD, Hallym University Kangnam Sacred Heart Hospital
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- kangnamANE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Ataturk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Virginia Commonwealth UniversityRecruitingCesarean SectionUnited States
-
University Tunis El ManarCompleted
-
Federico II UniversityCompletedCesarean SectionItaly
-
Virginia Commonwealth UniversityCompletedCesarean SectionUnited States
-
University of CalgaryCompleted
-
The Affiliated Hospital of Xuzhou Medical UniversityCompletedCesarean SectionChina
Clinical Trials on Temperature
-
Ege UniversityCompletedPrematurity | Feeding Disorder NeonatalTurkey
-
Karolinska InstitutetDanderyd Hospital; Stockholm South General HospitalWithdrawnSepsis | Critical Illness | Fluid Overload | Hemodynamic InstabilitySweden
-
University of BonnDLR German Aerospace CenterCompletedResting Energy ExpenditureGermany
-
Ajou University School of MedicineCompletedTrauma | Core TemperatureKorea, Republic of
-
Poitiers University HospitalCompletedContinuous Non Invasive Cutaneous Temperature | Zero Heat Flux Method | Esophageal Temperature | Arterial Temperature | Intracerebral TemperatureFrance
-
The University of Texas Health Science Center,...Zoll Medical Corporation; Vivian L. Smith Foundation for Neurologic ResearchTerminatedSubdural Hematoma, TraumaticUnited States, Japan
-
Ankara City Hospital BilkentCompletedHypothermia | Orthopedic Disorder | Hip ArthropathyTurkey
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
Fudan UniversityNot yet recruitingCognitive Function | Cardiovascular System | Respiratory SystemChina
-
Aalborg UniversityActive, not recruiting